| Dr Dylan Burns Alston, DO | |
|
3723 W 12600 S Ste 270b, Riverton, UT 84065 | |
| (801) 285-4610 | |
| (801) 285-4602 |
| Full Name | Dr Dylan Burns Alston |
|---|---|
| Gender | Male |
| Speciality | Dermatology |
| Experience | 11 Years |
| Location | 3723 W 12600 S Ste 270b, Riverton, Utah |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1457790180 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207N00000X | Dermatology | 577682 (Texas) | Secondary |
| 207N00000X | Dermatology | 10279690-1204 (Utah) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Intermountain Healthcare Services, Inc | 1850209420 | 3063 |
News Archive
ePlus inc. announced today that its subsidiary, ePlus Technology inc., has achieved HP PartnerONE Healthcare Elite status. HP partners who attain Healthcare Elite status are considered experts in the healthcare environment, with superior HP-validated industry qualifications in everything from small practices to large healthcare systems.
Burkina Faso, Mali, and Niger report the lowest number of confirmed meningitis A cases ever recorded during an epidemic season this year following the successful introduction of a new vaccine that could eliminate the primary cause of the deadly disease from Africa's meningitis belt, announced the Meningitis Vaccine Project (MVP) today, which spearheaded development of the vaccine.
The intercellular bacteria "Candidatus Neoehrlichia", as e.g. Borrelia, can be transferred by ticks. Approx. 4.2 % of indigenous ticks are infected with this rarely explored bacterium which, until today, has been exclusively identified as pathogenic bacterium in patients with an impairment of the immune system, such as in case of leukaemia, rheumatism or after organ transplantation.
Momenta Pharmaceuticals, Inc., a biotechnology company specializing in the characterization and engineering of complex mixture drugs, today announced that preclinical data for its novel drug candidate, M402, will be presented at the 101st Annual Meeting of the American Association for Cancer Research (AACR). The meeting will be held April 17-21, 2010 in Washington, DC.
› Verified 3 days ago
| Entity Name | Ihc Health Services Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1942325154 PECOS PAC ID: 1850209420 Enrollment ID: O20080610000303 |
News Archive
ePlus inc. announced today that its subsidiary, ePlus Technology inc., has achieved HP PartnerONE Healthcare Elite status. HP partners who attain Healthcare Elite status are considered experts in the healthcare environment, with superior HP-validated industry qualifications in everything from small practices to large healthcare systems.
Burkina Faso, Mali, and Niger report the lowest number of confirmed meningitis A cases ever recorded during an epidemic season this year following the successful introduction of a new vaccine that could eliminate the primary cause of the deadly disease from Africa's meningitis belt, announced the Meningitis Vaccine Project (MVP) today, which spearheaded development of the vaccine.
The intercellular bacteria "Candidatus Neoehrlichia", as e.g. Borrelia, can be transferred by ticks. Approx. 4.2 % of indigenous ticks are infected with this rarely explored bacterium which, until today, has been exclusively identified as pathogenic bacterium in patients with an impairment of the immune system, such as in case of leukaemia, rheumatism or after organ transplantation.
Momenta Pharmaceuticals, Inc., a biotechnology company specializing in the characterization and engineering of complex mixture drugs, today announced that preclinical data for its novel drug candidate, M402, will be presented at the 101st Annual Meeting of the American Association for Cancer Research (AACR). The meeting will be held April 17-21, 2010 in Washington, DC.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Dylan Burns Alston, DO 3723 W 12600 S Ste 270b, Riverton, UT 84065-7296 Ph: (801) 285-4610 | Dr Dylan Burns Alston, DO 3723 W 12600 S Ste 270b, Riverton, UT 84065 Ph: (801) 285-4610 |
News Archive
ePlus inc. announced today that its subsidiary, ePlus Technology inc., has achieved HP PartnerONE Healthcare Elite status. HP partners who attain Healthcare Elite status are considered experts in the healthcare environment, with superior HP-validated industry qualifications in everything from small practices to large healthcare systems.
Burkina Faso, Mali, and Niger report the lowest number of confirmed meningitis A cases ever recorded during an epidemic season this year following the successful introduction of a new vaccine that could eliminate the primary cause of the deadly disease from Africa's meningitis belt, announced the Meningitis Vaccine Project (MVP) today, which spearheaded development of the vaccine.
The intercellular bacteria "Candidatus Neoehrlichia", as e.g. Borrelia, can be transferred by ticks. Approx. 4.2 % of indigenous ticks are infected with this rarely explored bacterium which, until today, has been exclusively identified as pathogenic bacterium in patients with an impairment of the immune system, such as in case of leukaemia, rheumatism or after organ transplantation.
Momenta Pharmaceuticals, Inc., a biotechnology company specializing in the characterization and engineering of complex mixture drugs, today announced that preclinical data for its novel drug candidate, M402, will be presented at the 101st Annual Meeting of the American Association for Cancer Research (AACR). The meeting will be held April 17-21, 2010 in Washington, DC.
› Verified 3 days ago
Dr. Jana Foley Parker, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 3723 W 12600 S, Suite 270, Riverton, UT 84065 Phone: 801-285-4610 Fax: 801-285-4601 |